GOV.UK
UK NSC stakeholders learn how we turn screening requests into practice
Last month we held the third annual UK National Screening Committee (UK NSC) stakeholder event.
screening benefits and risks
New duty of candour toolkit published to support breast services
The newly published ‘Breast screening: interval cancers and duty of candour toolkit’ advises health professionals on how to communicate information on interval cancers to women who were previously screened in the programme.
Videos worth watching: Sir Muir Gray (part 2)
Watch the second part of Sir Muir Gray’s keynote speech from last year’s stakeholder conference.
Poo sticks saved my life, says bowel cancer screening fan Shane
This year, on 17 July, I went to Norfolk and Norwich University Hospital (NNUH) for a colonoscopy. For the uninitiated it’s where a highly trained individual sticks a camera up your bottom. Take it from me, it’s really quite painless, …
UK NSC reports on its year of screening recommendations
Screening in the UK: making effective recommendations 2016 to 2017 summarises all the screening recommendations made between 1 April 2016 and 31 March 2017 and the evidence behind those recommendations.
Is quality of life affected by having an aneurysm detected by screening?
Little is known about the effects on a man's quality of life of knowing he has an aneurysm that might eventually grow to a dangerous size that requires treatment.
Improving early access to sickle cell and thalassaemia screening
Early access to sickle cell and thalassaemia screening and the early offer of prenatal diagnosis (PND) is important in giving women and couples time to consider their options.
Parents’ stories: personal experiences of sickle cell and thalassaemia screening
As part of a wider investigation into why women are tested late, we commissioned the UK Thalassaemia Society (UKTS) and Sickle Cell Society (SCS) to carry out face to face interviews with women and couples who had recent experience of the SCT programme.
Can you tell the difference between the UK NSC and PHE? And does it matter?
Screening folk can be a loyal bunch – either that or it’s a difficult discipline to escape from! A colleague of mine recently reached the amazing milestone of working 30 years in screening, making me reflect on my own career.
New home test kit for bowel cancer screening: what GPs need to know
The programme will introduce a new improved home test kit for screening from April 2018. It is call a faecal immunochemical test (FIT) and it will replace the guaiac faecal occult blood test (gFOBt). It’s important that GPs and others working in primary care understand this change to the screening programme and its implications for their patients, so here is a brief summary.